1. Home
  2. IQV vs HLN Comparison

IQV vs HLN Comparison

Compare IQV & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$207.07

Market Cap

34.6B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.80

Market Cap

41.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
HLN
Founded
1982
2022
Country
United States
United Kingdom
Employees
93000
24524
Industry
Biotechnology: Commercial Physical & Biological Resarch
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
41.1B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IQV
HLN
Price
$207.07
$9.80
Analyst Decision
Strong Buy
Buy
Analyst Count
16
1
Target Price
$227.13
N/A
AVG Volume (30 Days)
1.5M
10.4M
Earning Date
05-05-2026
02-26-2026
Dividend Yield
N/A
1.94%
EPS Growth
4.67
N/A
EPS
1.61
N/A
Revenue
$9,739,000,000.00
N/A
Revenue This Year
$6.77
$6.55
Revenue Next Year
$5.89
$4.42
P/E Ratio
$128.19
$49.05
Revenue Growth
41.60
N/A
52 Week Low
$154.50
$8.65
52 Week High
$247.05
$11.28

Technical Indicators

Market Signals
Indicator
IQV
HLN
Relative Strength Index (RSI) 73.43 68.65
Support Level $159.91 $9.62
Resistance Level $209.48 $10.05
Average True Range (ATR) 6.76 0.13
MACD 2.83 0.08
Stochastic Oscillator 97.29 100.00

Price Performance

Historical Comparison
IQV
HLN

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: